Please wait while the formulary information is being retrieved.
ADRUCIL (FLUOROURACIL)
- Adenocarcinoma of pancreas
- Colorectal cancer
- Metastatic breast carcinoma
- Gastric cancer
- Metastatic colorectal cancer
- Fluorouracil Iv
- Fluorouracil Intravenous Solution
- Adrucil Iv
- Adrucil Intravenous Solution
- By Indication
1 gram/20 mL intravenous solution
- Dosage information is not available
2.5 gram/50 mL intravenous solution
- Dosage information is not available
5 gram/100 mL intravenous solution
- Dosage information is not available
500 mg/10 mL intravenous solution
- Dosage information is not available
1 gram/20 mL intravenous solution
- Dosage information is not available
2.5 gram/50 mL intravenous solution
- Dosage information is not available
5 gram/100 mL intravenous solution
- Dosage information is not available
500 mg/10 mL intravenous solution
- Dosage information is not available
2.5 gram/50 mL intravenous solution
- Dosage information is not available
5 gram/100 mL intravenous solution
- Dosage information is not available
500 mg/10 mL intravenous solution
- Dosage information is not available
2.5 gram/50 mL intravenous solution
- Dosage information is not available
5 gram/100 mL intravenous solution
- Dosage information is not available
500 mg/10 mL intravenous solution
- Dosage information is not available
Gastric cancer
- Infuse 50 mg/m2/hour by continuous infusion route for 2 days
- Infuse 50 mg/m2/hour by continuous infusion route for 3 days
- Infuse 10.42 mg/m2/hour by continuous infusion route for 5 days
- Infuse 10.42 mg/m2/hour by continuous infusion route for 7 days
- Infuse 8.33 mg/m2/hour by continuous infusion route for 21 days
- Infuse 12.5 mg/m2/hour by continuous infusion route for 5 days
- Infuse 12.5 mg/m2/hour by continuous infusion route for 14 days
- Infuse 25 mg/m2/hour by continuous infusion route for 2 days
- Infuse 41.67 mg/m2/hour by continuous infusion route for 2 days
- Infuse 41.67 mg/m2/hour by continuous infusion route for 5 days
- Infuse 33.3 mg/m2/hour by continuous infusion route for 5 days
- Infuse 400 mg/m2 over 5-15 minute(s) by intravenous route once daily for 4 days
- Infuse 400 mg/m2 over 5-15 minute(s) by intravenous route once daily for 2 days
- Inject 400 mg/m2 over 5-15 minute(s) by intravenous route once daily for 2 days
- Inject 400 mg/m2 over 5-15 minute(s) by intravenous route once daily for 4 days
- Inject 180 mg/m2 over 5-15 minute(s) by intravenous route once daily for 33 days
- Infuse 180 mg/m2 over 5-15 minute(s) by intravenous route once daily for 33 days
- Infuse 200 mg/m2 over 5-15 minute(s) by intravenous route once daily for 42 days
- Infuse 200 mg/m2 over 5-15 minute(s) by intravenous route once daily for 5 days
- Inject 200 mg/m2 over 5-15 minute(s) by intravenous route once daily for 5 days
- Inject 200 mg/m2 over 5-15 minute(s) by intravenous route once daily for 42 days
- Infuse 500 mg/m2 over 15 minute(s) by intravenous route once weekly on days 1, 8 and 15 of treatment cycle
- Infuse 300 mg/m2 over 5-15 minute(s) by intravenous route once daily for 5 days
- Infuse 300 mg/m2 over 5-15 minute(s) by intravenous route once daily for 42 days
- Inject 300 mg/m2 over 5-15 minute(s) by intravenous route once daily for 42 days
- Inject 300 mg/m2 over 5-15 minute(s) by intravenous route once daily for 5 days
- Infuse 425 mg/m2 over 5-15 minute(s) by intravenous route once daily for 5 days
- Inject 425 mg/m2 over 5-15 minute(s) by intravenous route once daily for 5 days
- Inject 225 mg/m2 over 5-15 minute(s) by intravenous route once daily for 33 days
- Infuse 225 mg/m2 over 5-15 minute(s) by intravenous route once daily for 33 days
Keloid
- Inject 1 milliliter (50 mg) into affected lesion(s) by intralesional route once
Malignant esophagus neoplasm
- Infuse 50 mg/m2/hour by continuous infusion route for 2 days
- Infuse 50 mg/m2/hour by continuous infusion route for 3 days
- Infuse 10.42 mg/m2/hour by continuous infusion route for 5 days
- Infuse 10.42 mg/m2/hour by continuous infusion route for 7 days
- Infuse 8.33 mg/m2/hour by continuous infusion route for 21 days
- Infuse 12.5 mg/m2/hour by continuous infusion route for 5 days
- Infuse 12.5 mg/m2/hour by continuous infusion route for 14 days
- Infuse 25 mg/m2/hour by continuous infusion route for 2 days
- Infuse 41.67 mg/m2/hour by continuous infusion route for 2 days
- Infuse 41.67 mg/m2/hour by continuous infusion route for 5 days
- Infuse 33.3 mg/m2/hour by continuous infusion route for 5 days
- Infuse 400 mg/m2 over 5-15 minute(s) by intravenous route once daily for 4 days
- Infuse 400 mg/m2 over 5-15 minute(s) by intravenous route once daily for 2 days
- Inject 400 mg/m2 over 5-15 minute(s) by intravenous route once daily for 2 days
- Inject 400 mg/m2 over 5-15 minute(s) by intravenous route once daily for 4 days
- Inject 180 mg/m2 over 5-15 minute(s) by intravenous route once daily for 33 days
- Infuse 180 mg/m2 over 5-15 minute(s) by intravenous route once daily for 33 days
- Infuse 200 mg/m2 over 5-15 minute(s) by intravenous route once daily for 42 days
- Infuse 200 mg/m2 over 5-15 minute(s) by intravenous route once daily for 5 days
- Inject 200 mg/m2 over 5-15 minute(s) by intravenous route once daily for 5 days
- Inject 200 mg/m2 over 5-15 minute(s) by intravenous route once daily for 42 days
- Infuse 500 mg/m2 over 15 minute(s) by intravenous route once weekly on days 1, 8 and 15 of treatment cycle
- Infuse 300 mg/m2 over 5-15 minute(s) by intravenous route once daily for 5 days
- Infuse 300 mg/m2 over 5-15 minute(s) by intravenous route once daily for 42 days
- Inject 300 mg/m2 over 5-15 minute(s) by intravenous route once daily for 42 days
- Inject 300 mg/m2 over 5-15 minute(s) by intravenous route once daily for 5 days
- Infuse 425 mg/m2 over 5-15 minute(s) by intravenous route once daily for 5 days
- Inject 425 mg/m2 over 5-15 minute(s) by intravenous route once daily for 5 days
- Inject 225 mg/m2 over 5-15 minute(s) by intravenous route once daily for 33 days
- Infuse 225 mg/m2 over 5-15 minute(s) by intravenous route once daily for 33 days
Metastatic colorectal cancer
- Infuse 50 mg/m2/hour by continuous infusion route for 2 days
- Infuse 9.36 mg/m2/hour by continuous infusion route for 5 days
- Infuse 9.36 mg/m2/hour by continuous infusion route for 7 days
- Infuse 66.67 mg/m2/hour by continuous infusion route for 2 days
- Inject 500 mg/m2 over 5-15 minute(s) by intravenous route once weeklyon days 1, 8, 15, 22, 29 and 36 of treatment cycle
- Infuse 500 mg/m2 over 5-15 minute(s) by intravenous route once weeklyon days 1, 8, 15, 22, 29 and 36 of treatment cycle
- adenovirus vac live type-4 & 7
- adenovirus vaccine live type-4
- adenovirus vaccine live type-7
- BCG vaccine, live (PF)
- flu vac,qval 2013-14 (2-49yrs)
- Flumist 2013-2014
- M-m-r Ii (pf)
- measles,mumps&rubella vacc(PF)
- measles,mumps,rub,varicel(PF)
- natalizumab
- Proquad (pf)
- Rotateq Vaccine
- rotavirus vaccine live, penta
- typhoid vaccine
- Tysabri
- varicella virus vacc live (PF)
- Varivax (pf)
- Vivotif Berna Vaccine
- yellow fever vaccine live (PF)
- Yf-vax (pf)
- Zostavax (pf)
- zoster vaccine live (PF)
Contraindicated
- clozapine
- Clozaril
- Coumadin
- deferiprone
- Fazaclo
- Ferriprox
- Flagyl
- Flagyl Er
- Jantoven
- Metro I.v.
- metronidazole
- metronidazole in NaCl (iso-os)
- Tindamax
- tinidazole
- Versacloz
- warfarin
Severe
Moderate
- Cerebyx
- Dilantin
- Dilantin Extended
- Dilantin Infatabs
- Dilantin Kapseal
- Dilantin-125
- Enlyte
- ethotoin
- FA#5-Fe-C-Ca th-p dha-vit B#14
- fosphenytoin
- leucovorin calcium
- Peganone
- Phenytek
- phenytoin
- phenytoin sodium
- phenytoin sodium extended
- Bone marrow depression
- Dihydropyrimidine dehydrogenase deficiency
- Gastrointestinal hemorrhage
- Hemorrhage
- Lactating mother
- Palmar-plantar erythrodysesthesia
- Pharyngitis
- Protein-calorie malnutrition
- Severe infection
- Severe thrombocytopenia
- Severe vomiting
- Stomatitis
Contraindicated
- Angina
- Diarrhea
- Disease of liver
- Gastrointestinal ulcer
- Kidney disease with reduction in GFR
- Leukopenia
- Neutropenic disorder
- Pregnancy
- Secondary malignant neoplasm of bone marrow
- Thrombocytopenic disorder
Severe
Moderate
- None
ADRUCIL (FLUOROURACIL)
- Adenocarcinoma of pancreas
- Colorectal cancer
- Metastatic breast carcinoma
- Gastric cancer
- Metastatic colorectal cancer
- Allergic dermatitis
- Aphthous stomatitis
- Diarrhea
- Heartburn
- Infection
- Leukopenia
- Pruritus of skin
- Skin rash
- Alopecia
- Anorexia
- Esophagitis
- Fatigue
- General weakness
- Nausea
- Pharyngitis
- Stomatitis
- Vomiting
More Frequent
Severe
Less Severe
- Anemia
- Gastrointestinal ulcer
- Neutropenic disorder
- Thrombocytopenic disorder
- Dry skin
- Skin photosensitivity
- Visual changes
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute cerebellar syndrome
- Acute myocardial infarction
- Agranulocytosis
- Anaphylaxis
- Angina
- Bone marrow depression
- Cardiac arrhythmia
- Coma
- Gastrointestinal hemorrhage
- Heart failure
- Hyperammonemia
- Maculopapular rash
- Myocardial ischemia
- Pancytopenia
- Pulmonary disease
- Thrombophlebitis
Less Severe
- Acute confusion
- Ataxia
- Epistaxis
- Euphoria
- Eye tearing
- Headache disorder
- Nail disorders
- Nasolacrimal duct stenosis
- Nystagmus
- Palmar-plantar erythrodysesthesia
- Photophobia
- Skin fissure
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Fluorouracil
Safety and efficacy not established.
- 1 Day – 18 Years
- Safety and efficacy not established.
Fluorouracil (systemic)
- Severity Level:
D
- Additional Notes:
Contraindicated
Fluorouracil (systemic)
Cytotoxic drug, molecular weight low enough for possible breastmilk excretion
| General | Excretion Potential | Effect on Infant | Notes |
| Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Cytotoxic drug, molecular weight low enough for possible breastmilk excretion |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Adenocarcinoma of pancreas | |
| C24.1 | Malignant neoplasm of ampulla of vater |
| C25 | Malignant neoplasm of pancreas |
| C25.0 | Malignant neoplasm of head of pancreas |
| C25.1 | Malignant neoplasm of body of pancreas |
| C25.2 | Malignant neoplasm of tail of pancreas |
| C25.3 | Malignant neoplasm of pancreatic duct |
| C25.4 | Malignant neoplasm of endocrine pancreas |
| C25.7 | Malignant neoplasm of other parts of pancreas |
| C25.8 | Malignant neoplasm of overlapping sites of pancreas |
| C25.9 | Malignant neoplasm of pancreas, unspecified |
| Colorectal cancer | |
| C18 | Malignant neoplasm of colon |
| C18.0 | Malignant neoplasm of cecum |
| C18.1 | Malignant neoplasm of appendix |
| C18.2 | Malignant neoplasm of ascending colon |
| C18.3 | Malignant neoplasm of hepatic flexure |
| C18.4 | Malignant neoplasm of transverse colon |
| C18.5 | Malignant neoplasm of splenic flexure |
| C18.6 | Malignant neoplasm of descending colon |
| C18.7 | Malignant neoplasm of sigmoid colon |
| C18.8 | Malignant neoplasm of overlapping sites of colon |
| C18.9 | Malignant neoplasm of colon, unspecified |
| C19 | Malignant neoplasm of rectosigmoid junction |
| C20 | Malignant neoplasm of rectum |
| C21.8 | Malignant neoplasm of overlapping sites of rectum, anus and anal canal |
| Gastric cancer | |
| C16 | Malignant neoplasm of stomach |
| C16.0 | Malignant neoplasm of cardia |
| C16.1 | Malignant neoplasm of fundus of stomach |
| C16.2 | Malignant neoplasm of body of stomach |
| C16.3 | Malignant neoplasm of pyloric antrum |
| C16.4 | Malignant neoplasm of pylorus |
| C16.5 | Malignant neoplasm of lesser curvature of stomach, unspecified |
| C16.6 | Malignant neoplasm of greater curvature of stomach, unspecified |
| C16.8 | Malignant neoplasm of overlapping sites of stomach |
| C16.9 | Malignant neoplasm of stomach, unspecified |
| Metastatic breast carcinoma | |
| C50 | Malignant neoplasm of breast |
| C50.1 | Malignant neoplasm of central portion of breast |
| C50.11 | Malignant neoplasm of central portion of breast, female |
| C50.111 | Malignant neoplasm of central portion of right female breast |
| C50.112 | Malignant neoplasm of central portion of left female breast |
| C50.119 | Malignant neoplasm of central portion of unspecified female breast |
| C50.12 | Malignant neoplasm of central portion of breast, male |
| C50.121 | Malignant neoplasm of central portion of right male breast |
| C50.122 | Malignant neoplasm of central portion of left male breast |
| C50.129 | Malignant neoplasm of central portion of unspecified male breast |
| C50.2 | Malignant neoplasm of upper-inner quadrant of breast |
| C50.21 | Malignant neoplasm of upper-inner quadrant of breast, female |
| C50.211 | Malignant neoplasm of upper-inner quadrant of right female breast |
| C50.212 | Malignant neoplasm of upper-inner quadrant of left female breast |
| C50.219 | Malignant neoplasm of upper-inner quadrant of unspecified female breast |
| C50.22 | Malignant neoplasm of upper-inner quadrant of breast, male |
| C50.221 | Malignant neoplasm of upper-inner quadrant of right male breast |
| C50.222 | Malignant neoplasm of upper-inner quadrant of left male breast |
| C50.229 | Malignant neoplasm of upper-inner quadrant of unspecified male breast |
| C50.3 | Malignant neoplasm of lower-inner quadrant of breast |
| C50.31 | Malignant neoplasm of lower-inner quadrant of breast, female |
| C50.311 | Malignant neoplasm of lower-inner quadrant of right female breast |
| C50.312 | Malignant neoplasm of lower-inner quadrant of left female breast |
| C50.319 | Malignant neoplasm of lower-inner quadrant of unspecified female breast |
| C50.32 | Malignant neoplasm of lower-inner quadrant of breast, male |
| C50.321 | Malignant neoplasm of lower-inner quadrant of right male breast |
| C50.322 | Malignant neoplasm of lower-inner quadrant of left male breast |
| C50.329 | Malignant neoplasm of lower-inner quadrant of unspecified male breast |
| C50.4 | Malignant neoplasm of upper-outer quadrant of breast |
| C50.41 | Malignant neoplasm of upper-outer quadrant of breast, female |
| C50.411 | Malignant neoplasm of upper-outer quadrant of right female breast |
| C50.412 | Malignant neoplasm of upper-outer quadrant of left female breast |
| C50.419 | Malignant neoplasm of upper-outer quadrant of unspecified female breast |
| C50.42 | Malignant neoplasm of upper-outer quadrant of breast, male |
| C50.421 | Malignant neoplasm of upper-outer quadrant of right male breast |
| C50.422 | Malignant neoplasm of upper-outer quadrant of left male breast |
| C50.429 | Malignant neoplasm of upper-outer quadrant of unspecified male breast |
| C50.5 | Malignant neoplasm of lower-outer quadrant of breast |
| C50.51 | Malignant neoplasm of lower-outer quadrant of breast, female |
| C50.511 | Malignant neoplasm of lower-outer quadrant of right female breast |
| C50.512 | Malignant neoplasm of lower-outer quadrant of left female breast |
| C50.519 | Malignant neoplasm of lower-outer quadrant of unspecified female breast |
| C50.52 | Malignant neoplasm of lower-outer quadrant of breast, male |
| C50.521 | Malignant neoplasm of lower-outer quadrant of right male breast |
| C50.522 | Malignant neoplasm of lower-outer quadrant of left male breast |
| C50.529 | Malignant neoplasm of lower-outer quadrant of unspecified male breast |
| C50.6 | Malignant neoplasm of axillary tail of breast |
| C50.61 | Malignant neoplasm of axillary tail of breast, female |
| C50.611 | Malignant neoplasm of axillary tail of right female breast |
| C50.612 | Malignant neoplasm of axillary tail of left female breast |
| C50.619 | Malignant neoplasm of axillary tail of unspecified female breast |
| C50.62 | Malignant neoplasm of axillary tail of breast, male |
| C50.621 | Malignant neoplasm of axillary tail of right male breast |
| C50.622 | Malignant neoplasm of axillary tail of left male breast |
| C50.629 | Malignant neoplasm of axillary tail of unspecified male breast |
| C50.8 | Malignant neoplasm of overlapping sites of breast |
| C50.81 | Malignant neoplasm of overlapping sites of breast, female |
| C50.811 | Malignant neoplasm of overlapping sites of right female breast |
| C50.812 | Malignant neoplasm of overlapping sites of left female breast |
| C50.819 | Malignant neoplasm of overlapping sites of unspecified female breast |
| C50.82 | Malignant neoplasm of overlapping sites of breast, male |
| C50.821 | Malignant neoplasm of overlapping sites of right male breast |
| C50.822 | Malignant neoplasm of overlapping sites of left male breast |
| C50.829 | Malignant neoplasm of overlapping sites of unspecified male breast |
| C50.9 | Malignant neoplasm of breast of unspecified site |
| C50.91 | Malignant neoplasm of breast of unspecified site, female |
| C50.911 | Malignant neoplasm of unspecified site of right female breast |
| C50.912 | Malignant neoplasm of unspecified site of left female breast |
| C50.919 | Malignant neoplasm of unspecified site of unspecified female breast |
| C50.92 | Malignant neoplasm of breast of unspecified site, male |
| C50.921 | Malignant neoplasm of unspecified site of right male breast |
| C50.922 | Malignant neoplasm of unspecified site of left male breast |
| C50.929 | Malignant neoplasm of unspecified site of unspecified male breast |
| Metastatic colorectal cancer | |
| C18 | Malignant neoplasm of colon |
| C18.0 | Malignant neoplasm of cecum |
| C18.1 | Malignant neoplasm of appendix |
| C18.2 | Malignant neoplasm of ascending colon |
| C18.3 | Malignant neoplasm of hepatic flexure |
| C18.4 | Malignant neoplasm of transverse colon |
| C18.5 | Malignant neoplasm of splenic flexure |
| C18.6 | Malignant neoplasm of descending colon |
| C18.7 | Malignant neoplasm of sigmoid colon |
| C18.8 | Malignant neoplasm of overlapping sites of colon |
| C18.9 | Malignant neoplasm of colon, unspecified |
| C19 | Malignant neoplasm of rectosigmoid junction |
| C20 | Malignant neoplasm of rectum |
| C21.8 | Malignant neoplasm of overlapping sites of rectum, anus and anal canal |
| 0-9 | A-Z |
|---|---|
| C16 | Malignant neoplasm of stomach |
| C16.0 | Malignant neoplasm of cardia |
| C16.1 | Malignant neoplasm of fundus of stomach |
| C16.2 | Malignant neoplasm of body of stomach |
| C16.3 | Malignant neoplasm of pyloric antrum |
| C16.4 | Malignant neoplasm of pylorus |
| C16.5 | Malignant neoplasm of lesser curvature of stomach, unspecified |
| C16.6 | Malignant neoplasm of greater curvature of stomach, unspecified |
| C16.8 | Malignant neoplasm of overlapping sites of stomach |
| C16.9 | Malignant neoplasm of stomach, unspecified |
| C18 | Malignant neoplasm of colon |
| C18 | Malignant neoplasm of colon |
| C18.0 | Malignant neoplasm of cecum |
| C18.0 | Malignant neoplasm of cecum |
| C18.1 | Malignant neoplasm of appendix |
| C18.1 | Malignant neoplasm of appendix |
| C18.2 | Malignant neoplasm of ascending colon |
| C18.2 | Malignant neoplasm of ascending colon |
| C18.3 | Malignant neoplasm of hepatic flexure |
| C18.3 | Malignant neoplasm of hepatic flexure |
| C18.4 | Malignant neoplasm of transverse colon |
| C18.4 | Malignant neoplasm of transverse colon |
| C18.5 | Malignant neoplasm of splenic flexure |
| C18.5 | Malignant neoplasm of splenic flexure |
| C18.6 | Malignant neoplasm of descending colon |
| C18.6 | Malignant neoplasm of descending colon |
| C18.7 | Malignant neoplasm of sigmoid colon |
| C18.7 | Malignant neoplasm of sigmoid colon |
| C18.8 | Malignant neoplasm of overlapping sites of colon |
| C18.8 | Malignant neoplasm of overlapping sites of colon |
| C18.9 | Malignant neoplasm of colon, unspecified |
| C18.9 | Malignant neoplasm of colon, unspecified |
| C19 | Malignant neoplasm of rectosigmoid junction |
| C19 | Malignant neoplasm of rectosigmoid junction |
| C20 | Malignant neoplasm of rectum |
| C20 | Malignant neoplasm of rectum |
| C21.8 | Malignant neoplasm of overlapping sites of rectum, anus and anal canal |
| C21.8 | Malignant neoplasm of overlapping sites of rectum, anus and anal canal |
| C24.1 | Malignant neoplasm of ampulla of vater |
| C25 | Malignant neoplasm of pancreas |
| C25.0 | Malignant neoplasm of head of pancreas |
| C25.1 | Malignant neoplasm of body of pancreas |
| C25.2 | Malignant neoplasm of tail of pancreas |
| C25.3 | Malignant neoplasm of pancreatic duct |
| C25.4 | Malignant neoplasm of endocrine pancreas |
| C25.7 | Malignant neoplasm of other parts of pancreas |
| C25.8 | Malignant neoplasm of overlapping sites of pancreas |
| C25.9 | Malignant neoplasm of pancreas, unspecified |
| C50 | Malignant neoplasm of breast |
| C50.1 | Malignant neoplasm of central portion of breast |
| C50.11 | Malignant neoplasm of central portion of breast, female |
| C50.111 | Malignant neoplasm of central portion of right female breast |
| C50.112 | Malignant neoplasm of central portion of left female breast |
| C50.119 | Malignant neoplasm of central portion of unspecified female breast |
| C50.12 | Malignant neoplasm of central portion of breast, male |
| C50.121 | Malignant neoplasm of central portion of right male breast |
| C50.122 | Malignant neoplasm of central portion of left male breast |
| C50.129 | Malignant neoplasm of central portion of unspecified male breast |
| C50.2 | Malignant neoplasm of upper-inner quadrant of breast |
| C50.21 | Malignant neoplasm of upper-inner quadrant of breast, female |
| C50.211 | Malignant neoplasm of upper-inner quadrant of right female breast |
| C50.212 | Malignant neoplasm of upper-inner quadrant of left female breast |
| C50.219 | Malignant neoplasm of upper-inner quadrant of unspecified female breast |
| C50.22 | Malignant neoplasm of upper-inner quadrant of breast, male |
| C50.221 | Malignant neoplasm of upper-inner quadrant of right male breast |
| C50.222 | Malignant neoplasm of upper-inner quadrant of left male breast |
| C50.229 | Malignant neoplasm of upper-inner quadrant of unspecified male breast |
| C50.3 | Malignant neoplasm of lower-inner quadrant of breast |
| C50.31 | Malignant neoplasm of lower-inner quadrant of breast, female |
| C50.311 | Malignant neoplasm of lower-inner quadrant of right female breast |
| C50.312 | Malignant neoplasm of lower-inner quadrant of left female breast |
| C50.319 | Malignant neoplasm of lower-inner quadrant of unspecified female breast |
| C50.32 | Malignant neoplasm of lower-inner quadrant of breast, male |
| C50.321 | Malignant neoplasm of lower-inner quadrant of right male breast |
| C50.322 | Malignant neoplasm of lower-inner quadrant of left male breast |
| C50.329 | Malignant neoplasm of lower-inner quadrant of unspecified male breast |
| C50.4 | Malignant neoplasm of upper-outer quadrant of breast |
| C50.41 | Malignant neoplasm of upper-outer quadrant of breast, female |
| C50.411 | Malignant neoplasm of upper-outer quadrant of right female breast |
| C50.412 | Malignant neoplasm of upper-outer quadrant of left female breast |
| C50.419 | Malignant neoplasm of upper-outer quadrant of unspecified female breast |
| C50.42 | Malignant neoplasm of upper-outer quadrant of breast, male |
| C50.421 | Malignant neoplasm of upper-outer quadrant of right male breast |
| C50.422 | Malignant neoplasm of upper-outer quadrant of left male breast |
| C50.429 | Malignant neoplasm of upper-outer quadrant of unspecified male breast |
| C50.5 | Malignant neoplasm of lower-outer quadrant of breast |
| C50.51 | Malignant neoplasm of lower-outer quadrant of breast, female |
| C50.511 | Malignant neoplasm of lower-outer quadrant of right female breast |
| C50.512 | Malignant neoplasm of lower-outer quadrant of left female breast |
| C50.519 | Malignant neoplasm of lower-outer quadrant of unspecified female breast |
| C50.52 | Malignant neoplasm of lower-outer quadrant of breast, male |
| C50.521 | Malignant neoplasm of lower-outer quadrant of right male breast |
| C50.522 | Malignant neoplasm of lower-outer quadrant of left male breast |
| C50.529 | Malignant neoplasm of lower-outer quadrant of unspecified male breast |
| C50.6 | Malignant neoplasm of axillary tail of breast |
| C50.61 | Malignant neoplasm of axillary tail of breast, female |
| C50.611 | Malignant neoplasm of axillary tail of right female breast |
| C50.612 | Malignant neoplasm of axillary tail of left female breast |
| C50.619 | Malignant neoplasm of axillary tail of unspecified female breast |
| C50.62 | Malignant neoplasm of axillary tail of breast, male |
| C50.621 | Malignant neoplasm of axillary tail of right male breast |
| C50.622 | Malignant neoplasm of axillary tail of left male breast |
| C50.629 | Malignant neoplasm of axillary tail of unspecified male breast |
| C50.8 | Malignant neoplasm of overlapping sites of breast |
| C50.81 | Malignant neoplasm of overlapping sites of breast, female |
| C50.811 | Malignant neoplasm of overlapping sites of right female breast |
| C50.812 | Malignant neoplasm of overlapping sites of left female breast |
| C50.819 | Malignant neoplasm of overlapping sites of unspecified female breast |
| C50.82 | Malignant neoplasm of overlapping sites of breast, male |
| C50.821 | Malignant neoplasm of overlapping sites of right male breast |
| C50.822 | Malignant neoplasm of overlapping sites of left male breast |
| C50.829 | Malignant neoplasm of overlapping sites of unspecified male breast |
| C50.9 | Malignant neoplasm of breast of unspecified site |
| C50.91 | Malignant neoplasm of breast of unspecified site, female |
| C50.911 | Malignant neoplasm of unspecified site of right female breast |
| C50.912 | Malignant neoplasm of unspecified site of left female breast |
| C50.919 | Malignant neoplasm of unspecified site of unspecified female breast |
| C50.92 | Malignant neoplasm of breast of unspecified site, male |
| C50.921 | Malignant neoplasm of unspecified site of right male breast |
| C50.922 | Malignant neoplasm of unspecified site of left male breast |
| C50.929 | Malignant neoplasm of unspecified site of unspecified male breast |
Formulary Reference Tool